DexCom Inc.

Company Snapshot

Founded: 1999
Entity Type: Public
Employees: 11,100
Region: U.S.
Revenue: $4,662.0 Millions
Revenue Year: 2025
Headquarter: California, U.S.
Key Geographics: U.S., International
Corporate Address: 6340 Sequence Drive San Diego, California 92121, U.S. Tel. +1-858-200-0200 www.dexcom.com

Company Overview

Dexcom Inc. is a medical device company specializing in continuous glucose monitoring technology. It focuses on enhancing diabetes care by providing real-time glucose insights that enable patients and healthcare providers to make informed decisions. Its product range includes the popular G6 and G7 systems and Stelo, the first over-the-counter CGM designed for people with type 2 diabetes and prediabetes. These products also support home care and long-term care.

Dexcom’s glucose monitoring technologies enable continuous and remote glucose tracking, allowing patients, caregivers and healthcare providers to monitor glucose levels without routine finger sticks. With cloud connectivity and integration into digital health platforms, it enhances glucose management and supports better decision-making across care settings.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

DexCom Inc. In Reports

Technologies for Long-Term Care and Home Healthcare: Global Markets

According to BCC Research detailed report on technologies for long-term care and home healthcare market trends with data from 2024, estimates from 2025, and projections of compound annual growth rates through 2030.

Global Markets for Diabetes Therapeutics and Diagnostics

According to BCC Research detailed report on Diabetes Therapeutics and Diagnostics Markets with data from 2024, estimates from 2025, and projections of compound annual growth rates through 2030 (forecast period...

Mobile Health (mHealth) Technologies and Global Markets

According to BCC Research detailed report on mobile health market revenue ($ Million) for the base year of 2024 and estimated data for 2025 and the forecast period 2026 through 2030.

Company's Business Segments

  • Distributor : Distribution agreement with market players for the supply of continuous glucose monitoring devices.

Applications/End User Industries

  • Healthcare
  • Patient Monitoring
  • Diabetes
  • Medical Devices
  • Continuous Glucose Monitoring
AI Sentiment